Autres langues China Isotope & Radiation Corporation

Actions

1763

CNE1000031F4

Equipement, fournitures et distribution médicale

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:15 03/07/2026			Varia. 5j.	Varia. 1 janv.
17,56 ^HKD	+1,68%		+1,50%	-13,07%

18/06	China Isotope & Radiation Corporation approuve le dividende final pour l'exercice 2025, payable avant le 17 août 2026	CI
18/06	China Isotope & Radiation Corporation nomme Zhang Guoliang au sein du comité des affaires juridiques et du comité de l'innovation scientifique et technologique du conseil d'administration	CI

Autres langues

18/06	China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026
18/06	China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board
27/05	China Isotope Proposes Auditor Change
26/05	China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026
27/03	China Isotope & Radiation final cash dividend of RMB0.2264 per share
27/03	China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026
27/03	China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025
19/03	China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection
13/03	China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement
13/03	China Isotope & Radiation says co and Zhonghe Headway enter strategic cooperation agreement with Maoming municipality
02/03	China Isotope & Radiation's Unit Gets China Nod for Market Launch of Breath Analyzer
12/02	China Isotope & Radiation Warns of Up to 25% Lower 2025 Profit
12/02	China Isotope & Radiation Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025
19/12	China Isotope & Radiation says Zhonghe Headway obtained clinical trial approval for BNCT boron drug
19/12	China Isotope & Radiation's Unit Gets China Nod for Trial of Tumor Drug
15/12	China Isotope & Radiation says unit entered commercial cooperation agreement with Novartis
12/12	China Isotope & Radiation Renews Contracts With CNNC
27/11	China Isotope & Radiation Corp says co, CNNC Capital enter strategic cooperation deal
27/11	China Isotope Partners With CNNC Capital on M&A and Investment Cooperation
27/11	China Isotope & Radiation Corporation and CNNC Capital Holdings Limited Enter into Strategic Cooperation Agreement
19/11	China Isotope & Radiation Secures Peru Deal for Export of Irradiation Equipment
18/11	China Isotope & Radiation Corporation Signs Contract with Peruvian Client in Lima for the Agricultural Gamma Irradiation Station Project
18/11	China Isotope Signs Deal to Supply Cobalt-60 to Brazil's Nuclear Authority
17/11	China Isotope & Radiation enters agreement with Brazil's National Nuclear Energy Commission
17/11	China Isotope & Radiation Corporation Enter into the Agreement on the Intended Purchase of Cobalt-60 Radioactive Sources for Irradiation Purpose with the National Nuclear Energy Commission of Brazil